Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

FDA Approval of Biopharma's Pain Drug Expected This Year

The reasons a green light is anticipated and how it relates to the closing of Avenue Therapeutics' pending acquisition are discussed in an H.C. Wainwright & Co. report. In a Feb. 13 research note, H.C. Wainwright & Co. analyst Ed Arce reported that the U.S. ...
Streetwise Reports | February 20, 2020 |

Understanding Fortress Biotech

Daniel Carlson of Tailwinds Research takes a close look at what he calls a "great value opportunity," with a focus on subsidiary Avenue Therapeutics. With a plethora of balls in the air, Fortress Biotech Inc. (FBIO:NASDAQ) is a very difficult company to va...
Streetwise Reports | February 6, 2020 |

17 best payday loans online: Quick cash and fast approval this Christmas

If you face a financial emergency, traditional loans may not be a viable option if you have bad credit. So what can you do when you need quick cash – especially close if you need cash for Christmas gifts during the festive season? The best online payday loans are an a...
Dominic Castleberry | December 11, 2023 |

Voxtur is the Leading Provider of Digital, SaaS Solutions for Real Estate Transactions in N. America

Before we dive into what makes Voxtur Analytics ( TSX-V: VXTR ; OTCQB: VXTRF) a standout PropTech company (and an undervalued investment opportunity), it’s worth highlighting a few recent developments: –Voxtur has seen revenues increase 300% year-over-year a...
Stockhouse Editorial | September 22, 2021 |

Coverage Initiated on 'Biotech Machine'

The compelling reasons behind those descriptors are explored in a Dawson James Securities report. In an Aug. 26 research note, analyst Jason Kolbert reported that DawsonJames Securities initiated coverage on Fortress Biotech Inc. (FBIO:NASDAQ) with a Buy rating and ...
Streetwise Reports | September 5, 2019 |

Is the time right for M&A in the mining sector?

Companies in the junior mining sector are currently operating in a challenging capital-raising environment. The mining industry is highly cyclical, making it susceptible to fluctuations in commodity prices and other macroeconomic headwinds, making investors cautious abou...
Research | October 5, 2023 |

A Key Gold Bull Market Signal

The gold market is looking a lot like it did early in the millennium, at the start of the bull market. It is setting up for a gold bull market that is likely to be way more intense than the previous one, due to the structural weaknesses incurred by the monetary system since th...
Hubert Moolman | June 21, 2019 |

NASDAQ Listing & $100M Sales Guidance Fuels Peak’s H2/21

eResearch is pleased to publish an update Equity Research Report on Peak Fintech Group (PKK) ( CSE.PKK , OTC: PKKFF , Forum ) pertaining to the recent release of its revenue & EBITDA guidance. We are maintaining our Speculative Buy rating and increasing our one-year pr...
Featured Submission | August 3, 2021 |

A Battle for the Ages

As I was watching the pompom news channel (CNBC), they went into full damage control over Thursday's massacre, and I thought to myself, "What markets or media bullet points do 'the boys' need to control today in order to avoid a weekly sell signal and ensuing panic?" In...
Streetwise Reports | June 16, 2020 |

Buzz on the Bullboards: One Step Closer to a Canadian-Made COVID Vaccine?

(Image via Theralase Technologies Inc.) Clinical-stage pharmaceutical company Theralase Technologies Inc. ( TSX-V: TLT , Forum ) has demonstrated proof-of-concept for its Canadian-made COVID-19 vaccine. In collaboration with the University of Manitoba (UM), t...
Stockhouse Editorial | February 9, 2022 |
1 2 3 4 5